Skip to main content

Altamont Pharma Acquisition Corp. (ALTP)

Altamont Pharma Acquisition will go public soon, but the exact IPO date is still unknown.
Stock Price: $10.00
Confirmed IPO price
Chart not available yet
Market Cap125.00M
Revenue (ttm)n/a
Net Income (ttm)n/a
Shares Out12.50M
EPS (ttm)n/a
PE Ration/a
Forward PEn/a
Ex-Dividend Daten/a
Previous Closen/a
Day's Rangen/a
52-Week Rangen/a
Price Targetn/a
Est. Earnings Daten/a

About ALTP

Altamont Pharma Acquisition is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. It is our intention to pursue prospective targets that are focused on healthcare innovation. We anticipate targeting companies domiciled in North America or Europe that are developing assets in the biopharma and medical technology sectors, which aligns with our management team’s experience in healthcare investing and dru...

IndustryBlank Checks / SPAC
IPO DatePending
CEOMark Pearson
CountryUnited States
Stock ExchangeNASDAQ
Ticker SymbolALTP
Full Company Profile


Healthcare SPAC Altamont Pharma Acquisition files for a $100 million IPO

Altamont Pharma Acquisition, a blank check company targeting the biopharma and medical technology sectors, filed on Tuesday with the SEC to raise up to $100 million in an initial public offering.

6 months ago - NASDAQ

Altamont Pharma Acquisition IPO Registration Document (S-1)

Altamont Pharma Acquisition Corp. has filed to go public with an IPO on the NASDAQ.

6 months ago - SEC